A new component of the mammalian cellular defence mechanism against tumour production is identified in a report in the 02 Dec 2004 issue of Nature (Vol. 432, No. 7017, pp. 639-645). The gene involved, Seladin-1, is somewhat of a surprise package, as it has previously been linked to Alzheimer's disease and cholesterol metabolism.
Expression of oncogenes can lead to the generation of cancer cells; faced with this threat, a cellular senescence (cell ageing) programme kicks in, which is thought to be a weapon in the fight against tumorigenesis. By carrying out a genetic screen, Konstantin Galaktionov and colleagues found that Seladin-1 mediates senescence induced by the protein Ras. Knocking out Seladin-1 side-stepped Ras-induced senescence in rat and human fibroblast cells, allowing the cells to become cancerous as a result of unregulated Ras activity. An interaction between Seladin-1 and the tumour suppressor p53, initiated by oncogenic and oxidative stress, lies at the heart of this regulatory effect of Seladin-1.
Konstantin Galaktionov (Baylor College of Medicine, Houston, TX, USA)
Tel: +1 713 798 8280, E-mail: email@example.com
(C) Nature press release.
Message posted by: Trevor M. D'Souza
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...